Browse > Article
http://dx.doi.org/10.4014/jmb.1906.06041

Trehalose Protects the Probiotic Yeast Saccharomyces boulardii against Oxidative Stress-Induced Cell Death  

Moon, Ji Eun (Department of Food and Biotechnology, Korea University)
Heo, Wan (Institutes of Natural Sciences, Korea University)
Lee, Sang Hoon (Department of Food and Biotechnology, Korea University)
Lee, Suk Hee (Department of Molecular Medicine, Cell and Matrix Research Institute, Kyungpook National University School of Medicine)
Lee, Hong Gu (Department of Animal Science and Technology, College of Animal Bioscience and Technology, Konkuk University)
Lee, Jin Hyup (Department of Food and Biotechnology, Korea University)
Kim, Young Jun (Department of Food and Biotechnology, Korea University)
Publication Information
Journal of Microbiology and Biotechnology / v.30, no.1, 2020 , pp. 54-61 More about this Journal
Abstract
Saccharomyces boulardii is the only probiotic yeast with US Food and Drug Administration approval. It is routinely used to prevent or treat acute diarrhea and other gastrointestinal disorders, including the antibiotic-associated diarrhea caused by Clostridium difficile infections. The formation of reactive oxygen species (ROS), specifically H2O2 during normal aerobic metabolism, contributes to programmed cell death and represents a risk to the viability of the probiotic microbe. Moreover, a loss of viability reduces the efficacy of the probiotic treatment. Therefore, inhibiting the accumulation of ROS in the oxidant environment could improve the viability of the probiotic yeast and lead to more efficacious treatment. Here, we provide evidence that supplementation with a non-reducing disaccharide, namely trehalose, enhanced the viability of S. boulardii exposed to an oxidative environment by preventing metacaspase YCA1-mediated programmed cell death through inhibition of intracellular ROS production. Our results suggest that supplementation with S. boulardii together with trehalose could increase the viability of the organism, and thus improve its effectiveness as a probiotic and as a treatment for acute diarrhea and other gastrointestinal disorders.
Keywords
Trehalose; probiotic; reactive oxygen species; programmed cell death;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. 2000. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 31: 1012-1017.   DOI
2 Tung JM, Dolovich LR, Lee CH. 2009. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review. Can. J. Gastroenterol. 23: 817-821.   DOI
3 Correa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. 2011. Treatment of acute diarrhea with Saccharomyces boulardii in infants. J. Pediatr. Gastroenterol. Nutr. 53: 497-501.   DOI
4 Dinleyici EC, Eren M, Yargic ZA, Dogan N, Vandenplas Y. 2009. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. Am. J. Trop. Med. Hyg. 80: 953-955.   DOI
5 Kelesidis T, Pothoulakis C. 2012. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap. Adv. Gastroenterol. 5: 111-125.   DOI
6 McFarland LV. 2010. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. 16: 2202-2222.   DOI
7 Vandenplas Y, Brunser O, Szajewska H. 2009. Saccharomyces boulardii in childhood. Eur. J. Pediatr. 168: 253-265.   DOI
8 Jamieson DJ. 1998. Oxidative stress responses of the yeast Saccharomyces cerevisiae. Yeast 14: 1511-1527.   DOI
9 Mariani D, Mathias CJ, da Silva CG, Herdeiro Rda S, Pereira R, Panek AD, et al. 2008. Involvement of glutathione transferases, Gtt1and Gtt2, with oxidative stress response generated by $H_{2}O_{2}$ during growth of Saccharomyces cerevisiae. Redox Rep. 13: 246-254.   DOI
10 Perrone GG, Tan SX, Dawes IW. 2008. Reactive oxygen species and yeast apoptosis. Biochim. Biophys. Acta 1783: 1354-1368.   DOI
11 Jamieson DJ. 1995. The effect of oxidative stress on Saccharomyces cerevisiae. Redox Rep. 1: 89-95.   DOI
12 Benaroudj N, Lee DH, Goldberg AL. 2001. Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J. Biol. Chem. 276: 24261-24267.   DOI
13 Herdeiro RS, Pereira MD, Panek AD, Eleutherio EC. 2006. Trehalose protects Saccharomyces cerevisiae from lipid peroxidation during oxidative stress. Biochim. Biophys. Acta 1760: 340-346.   DOI
14 Alugoju P, Janardhanshetty SS, Subaramanian S, Periyasamy L, Dyavaiah M. 2018. Quercetin protects yeast Saccharomyces cerevisiae pep4 mutant from oxidative and apoptotic stress and extends chronological lifespan. Curr. Microbiol. 75: 519-530.   DOI
15 Cascio V, Gittings D, Merloni K, Hurton M, Laprade D, Austriaco N. 2013. S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death. BMC Microbiol. 13: 35.   DOI
16 Gao Z, Wang H, Zhang B, Wu X, Zhang Y, Ge P, Chi G, Liang J. 2018. Trehalose inhibits $H_{2}O_{2}$-induced autophagic death in dopaminergic SH-SY5Y cells via mitigation of ROS-dependent endoplasmic reticulum stress and AMPK activation. Int. J. Med. Sci. 15: 1014-1024.   DOI
17 Dani C, Bonatto D, Salvador M, Pereira MD, Henriques JA, Eleutherio E. 2008. Antioxidant protection of resveratrol and catechin in Saccharomyces cerevisiae. J. Agric. Food Chem. 56: 4268-4272.   DOI
18 Martorell P, Forment JV, de Llanos R, Monton F, Llopis S, Gonzalez N, et al. 2011. Use of Saccharomyces cerevisiae and Caenorhabditis elegans as model organisms to study the effect of cocoa polyphenols in the resistance to oxidative stress. J. Agric. Food Chem. 59: 2077-2085.   DOI
19 Mendes V, Vilaca R, de Freitas V, Ferreira PM, Mateus N, Costa V. 2015. Effect of myricetin, pyrogallol, and phloroglucinol on yeast resistance to oxidative stress. Oxid. Med. Cell. Longev. 2015: 782504.   DOI
20 Luo Y, Li WM, Wang W. 2008. Trehalose: Protector of antioxidant enzymes or reactive oxygen species scavenger under heat stress? Environ. Exp. Bot. 63: 378-384.   DOI
21 Mazzoni C, Falcone C. 2008. Caspase-dependent apoptosis in yeast. Biochim. Biophys. Acta 1783: 1320-1327.   DOI
22 Millard PJ, Roth BL, Thi HP, Yue ST, Haugland RP. 1997. Development of the FUN-1 family of fluorescent probes for vacuole labeling and viability testing of yeasts. Appl. Environ. Microbiol. 63: 2897-2905.   DOI
23 Madeo F , Frohlich E, L igr M, G rey M, S igrist S J, Wolf DH, et al. 1999. Oxygen stress: a regulator of apoptosis in yeast. J. Cell Biol. 145: 757-767.   DOI
24 Madeo F, Carmona-Gutierrez D, Ring J, Buttner S, Eisenberg T, Kroemer G. 2009. Caspase-dependent and caspase-independent cell death pathways in yeast. Biochem. Biophys. Res. Commun. 382: 227-231.   DOI
25 Farrugia G, Balzan R. 2012. Oxidative stress and programmed cell death in yeast. Front. Oncol. 2: 64.   DOI
26 Izawa S, Inoue Y, Kimura A. 1995. Oxidative stress response in yeast: effect of glutathione on adaptation to hydrogen peroxide stress in Saccharomyces cerevisiae. FEBS Lett. 368: 73-76.   DOI
27 Madeo F, Frohlich E, Frohlich KU. 1997. A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell Biol. 139: 729-734.   DOI
28 Burhans WC, Weinberger M, Marchetti MA, Ramachandran L, D'Urso G, Huberman JA. 2003. Apoptosis-like yeast cell death in response to DNA damage and replication defects. Mutat. Res. 532: 227-243.   DOI
29 Treml J, Smejkal K. 2016. Flavonoids as Potent Scavengers of Hydroxyl Radicals. Compr. Rev. Food Sci. Food Saf. 15: 720-738.   DOI
30 Lefevre S, Sliwa D, Auchere F, Brossas C, Ruckenstuhl C, Boggetto N, et al. 2012. The yeast metacaspase is implicated in oxidative stress response in frataxin-deficient cells. FEBS Lett. 586: 143-148.   DOI
31 Pozzoni P, Riva A, Bellatorre AG, Amigoni M, Redaelli E, Ronchetti A, et al. 2012. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebocontrolled trial. Am. J. Gastroenterol. 107: 922-931.   DOI
32 Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, et al. 2013. Health benefits of probiotics: a review. ISRN Nutr. 2013: 481651.   DOI
33 Czerucka D, Piche T, Rampal P. 2007. Review article: yeast as probiotics -- Saccharomyces boulardii. Aliment. Pharmacol. Ther. 26: 767-778.   DOI
34 Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. 2012. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin. Biol. Ther. 12: 395-410.   DOI
35 Sudha MR, Bhonagiri S, Kumar MA. 2012. Oral consumption of potential probiotic Saccharomyces boulardii strain Unique 28 in patients with acute diarrhoea: a clinical report. Benef. Microbes 3: 145-150.   DOI